R R Grunert. Show Affiliations »
Abstract
Mesh: See more » AnimalsAntiviral Agents/therapeutic useCells, CulturedCost-Benefit AnalysisDisease Models, AnimalDrug Evaluation, PreclinicalHerpes Simplex/drug therapyHerpesviridae Infections/drug therapyHumansInfluenza, Human/drug therapyPicornaviridae Infections/drug therapyRhinovirus
Substances: See more » Antiviral Agents
Year: 1979 PMID: 227321 DOI: 10.1146/annurev.mi.33.100179.002003
Source DB: PubMed Journal: Annu Rev Microbiol ISSN: 0066-4227 Impact factor: 15.500